Squarepoint Ops LLC Penumbra Inc Call Options Transaction History

Squarepoint Ops LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$163.64 - $210.12 $81,820 - $105,060	-500 Reduced 13.16%	3,300 $640,000
Q2 2024 Aug 14, 2024	SELL	$172.27 - $223.95 $6.51 Million - $8.47 Million	-37,800 Reduced 90.87%	3,800 $683,000
Q1 2024 May 15, 2024	SELL	$220.09 - $273.15 $6.51 Million - $8.09 Million	-29,600 Reduced 41.57%	41,600 $9.28 Million
Q4 2023 Feb 14, 2024	BUY	$181.44 - $260.22 $9.83 Million - $14.1 Million	54,200 Added 318.82%	71,200 $17.9 Million
Q2 2023 Aug 14, 2023	BUY	$271.54 - $344.06 $4.62 Million - $5.85 Million	17,000 New	17,000 $5.85 Million

374

29.2M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.37B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.